You are here

Asia

RegenXBio sells Hunter syndrome gene therapy's U.S., Asia commercial rights for $110M upfront

Fierce Biotech

Tue, 01/14/25 - 09:59 am

Hunter Syndrome

Supply chains too often “last cog” implemented in clinical trials

Clinical Trials Arena

Mon, 12/9/24 - 11:08 am

clinical trials

Vaccine clinical trial spotlight on Southeast Asia as “unique” opportunity beckons

Clinical Trials Arena

Tue, 12/3/24 - 11:41 pm

clinical trials

Roche's Vabysmo shows potential to treat eye disorder common in Asia

Fierce Pharma

Fri, 11/22/24 - 11:19 am

age-related macular degeneration

BMS buys Asian rights to key growth drug Camzyos

Pharmaphorum

Wed, 10/25/23 - 09:46 am

Bristol Myers Squibb

obstructive hypertrophic cardiomyopathy

Eisai files Leqembi in Korea, as US prospects firm up

Pharmaphorum

Thu, 06/8/23 - 10:02 am

Alzheimer's disease

Astellas' menopause therapy accepted for FDA review 5 months after late-phase study mars record

Fierce Biotech

Thu, 08/18/22 - 12:40 pm

clinical trials

Merck KGaA launches Asia startup scheme to locate next generation of partnerships

Fierce Biotech

Fri, 07/15/22 - 10:52 am

Small RSV contender eyes 'first-to-market' opportunity with $225M Asia deal

Endpoints

Mon, 03/21/22 - 10:13 am

Bavarian Nordic

Kiniksa inks licensing deal to take a Regeneron castoff into Asian markets

Endpoints

Wed, 02/23/22 - 10:31 am

Kiniksa Pharmaceuticals

Huadong Medicine

Covid-19 vaccine maker Moderna to set up subsidiary in Singapore as it boosts regional presence

Today Online, Singapore

Wed, 02/16/22 - 10:55 am

Moderna Therapeutics

2 Medtech Giants Are Working to Enhance Cardiac Care in Southeast Asia

Medical Devices and Diagnostics Industry

Wed, 01/5/22 - 10:43 pm

Boston Scientific

interventional cardiology

Prestige BioPharma and Dr. Reddy’s partner to sell trastuzumab biosimilar

Pharmaceutical Business Review

Thu, 12/9/21 - 10:57 am

Prestige BioPharma

Is Vaccine Latecomer Inovio Making a Comeback?

Motley Fool

Wed, 09/29/21 - 11:05 am

clinical trials

Landos Biopharma teams up with LianBio for $218M-plus collab and sales deal for 2 immunology assets in Asia

Fierce Biotech

Mon, 05/17/21 - 10:44 am

Landos Biopharma

ulcerative colitis

Crohn's Disease

Samsung Biologics and AstraZeneca launch strategic manufacturing partnership

Biopharma Reporter

Tue, 09/22/20 - 10:49 am

Samsung BioLogics

drug manufacturing

Amgen Is Making 3 Big Bets -- Will They Pay Off for Investors?

Motley Fool

Sun, 02/2/20 - 11:54 pm

With Immunomedics ADC deal, Everest bolsters cancer pipeline

BioCentury

Mon, 04/29/19 - 08:50 pm

sacituzumab govitecan

Everest Medicines

Ascletis Pharma, Asia’s first pre-profit listed biotech, plunges in Hong Kong three days after debut

South China Morning Post

Sun, 08/5/18 - 12:31 pm

Arcus Biosciences Announces That Taiho Pharmaceutical Has Exercised Its Option to Develop and Commercialize AB928 in Its Territories

CP Wire

Fri, 07/13/18 - 11:55 am

Arcus Biosciences

Taiho Pharmaceutical

Pages